4th Pediatric Infectious Diseases Conference
 
 
Home  Back   ISSN 0973 - 0958
 
User name :
Password :
Pedi Poll
Today's Poll
Should teicoplannin, colistin be used in case of neonatal sepsis where culture does not reveal any organism_?
No, it should be used only after drug sensitivity report
Yes, under guidance of an infectious disease expert
NON - HODGKIN'S LYMPHOMA
Non Hodgkin's Lymphoma
Dr. Bharat R. Agarwal
Pediatric Hematologist-Oncologist,
Division of Pediatric Hem-Onco,
B.J. Wadia Hospital for Children


Non-Hodgkin's Lymphoma (NHL) results from the malignant proliferation of cells of lymphocytic lineage. Although malignant lymphomas are generally restricted to lymphoid tissue such as lymph nodes and spleen, it is not uncommon to find bone marrow involvement in children.

INCIDENCE AND EPIDEMIOLOGY

Incidence

  • NHL accounts for 5-7% of malignant diseases in childhood (Europe, United States). It is the third most common childhood malignancy

  • The incidence of NHL is higher in the Middle East, Nigeria, and Uganda (15 of 100,000 children under 5-10 years of age).

  • NHL accounts for 60% of all childhood lymphomas

  • Isolated cases of familial NHL have been known to occur.
Epidemiology

  • Sex : M:F= 2.5:1

  • Age : Peak age 5-15 years

  • Risk factors :-

    • Genetic- Immunological defects (Bruton's type of sex-linked agammaglobulinemia, common variable agammaglobulinemia, ataxia telangiectasia, Wiskott-Aldrich syndrome, severe combined immune deficiency)

    • Post-transplant immunosuppression - Post-bone marrow transplantation (especially with use of T-cell depleted marrow); post-liver or post-heart transplantation.

  • Drugs : Diphenylhydantoin

  • Radiation : Children treated with chemo-radiotherapy for Hodgkin's disease

  • Virus : Epstein-Barr virus (EBV), human immune deficiency virus (HIV)

PATHOLOGIC CLASSIFICATION

Table 1 presents the Revised European - American Lymphoma (REAL) classification from the International Lymphoma Study Group. This classification for NHL is based on the currently recognized histologic (morphologic), immunologic, and genetic features; their clinical presentation, and course. Currently, the REAL classification is the preferred classification for NHL.

Table 1 : Revised European-American Lymphoma Classification from the International Lymphoma Study Group


B-cell neoplasms

Precursor B-cell neoplasms

Precursor B-lymphoblastic leukemia / lymphoma

Peripheral B-cell neoplasms
  • B-cell CLL / PLL / SLL

  • Lymphoplasmacytoid lymphoma / immunocytoma

  • Mantle cell lymphoma

  • Follicle center lymphoma, follicular

    • Provisional cytologic grades: I (small), II (mixed), III (large)

    • Provisional subtype: diffuse, predominantly small cell

  • Marginal zone B-cell lymphoma

    • Extranodal (MALT ± monocytoid B cells)

    • Provisional category: nodal (± monocytoid B cells)

  • Provisional entity : splenic marginal zone lymphoma

  • Hairy cell leukemia

  • Plasmacytoma / myeloma

  • Diffuse large B-cell lymphoma

  • Burkitt's lymphoma

  • Provisional entity: high-grade B-cell lymphoma, Burkitt-type

T-cell and putative natural killer (NK) cell neoplasms

  • Precursor T-cell neoplasms

  • Precursor T-lymphoblastic lymphoma / leukemia

  • Peripheral T-cell and NK cell neoplasms

    • T-cell CLL / PLL

    • Large granular lymphocyte leukemia

    • Mycosis fungoides / Sezary syndrome

    • Peripheral T-cell lymphomas, unspecified

  • Provisional categories: medium, mixed, large, lymphoepitheloid

  • Provisional subtypes :

    • Hepatosplenic T-cell lymphoma

  • Subcutaneous panniculitic T-cell lymphoma

    • Adult T-cell lymphoma / leukemia

    • Angioimmunoblastic T-cell lymphoma

    • Angiocentric lymphoma

    • Intestinal T-cell lymphoma (± enteropathy)

    • Anaplastic large cell lymphoma (T/null)

    • Provisional ALCL Hodgkin's-like


Note : CLL, chronic lymphocytic leukemia; PLL prolymphocytic leukemia; SLL, small lymphocytic lymphoma, MALT,mucosal associated lymphoid tissue lymphoma; ALCL, anaplastic large cell lymphoma

From Harris NL, Jaffe ES, Stein H, Banks PM,Chan JKS, Cleary ML, Delsol G et al. A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group, Blood 1994, 84: 1361-92.

Fifty percent of NHL in children are small noncleaved, 30% lymphoblastic, and 20% large cell types.

 
 
Educational Section
 
Disclaimer:
The information given by www.pediatriconcall.com is provided by medical and paramedical & Health providers voluntarily for display & is meant only for informational purpose. The site does not guarantee the accuracy or authenticity of the information. Use of any information is solely at the user's own risk. The appearance of advertisement or product information in the various section in the website does not constitute an endorsement or approval by Pediatric Oncall of the quality or value of the said product or of claims made by its manufacturer.
 
copyright ©2011 website design & development by Levioza
Follow Us
Follow us on :
Folllow Us